Viking Therapeutics Company
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Employee Number:
1-10
Funding Status:
IPO
Headquarters:
San Diego, California, United States
Technology:
Cancer
Estimated Revenue:
$1M to $10M
Founded Date:
2012
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
PharmTech